Generic substitution--is it safe in patients at high cardiovascular risk?
Rayner
Brian
B
Department of Medicine, University of Cape Town.
Buchanan-Lee
Biddy
B
Brink
Johan
J
Opie
Lionel
L
D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000493:pharmacokinetics; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016568:Drugs, Generic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000009:adverse effects* / Q000493:pharmacokinetics; D012307:Risk Factors; D013810:Therapeutic Equivalency
D002121:Calcium Channel Blockers; D016568:Drugs, Generic; D009543:Nifedipine